Reductions in health spending were felt across Europe in 2013, according to OECD Health Statistics 2015.
Health spending continued to shrink in Greece, Italy and Portugal and most countries in the European Union reported real per capita health spending below the levels of 2009. In contrast, outside of Europe, health spending has been growing at around 2.5% per year since 2010.
Health spending growth has generally stayed in line with economic growth, so health expenditure as a share of GDP remained stable relative to 2012. This is in contrast to the years leading up to the economic crisis, when health spending strongly outpaced the rest of the economy. In 2013, health spending as a share of GDP was 8.9%, ranking from as low as 5.1% in Turkey to 16.4% in the USA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze